Clinical Research Directory
Browse clinical research sites, groups, and studies.
Aromatherapy Inhaler Use for HSCT Distress
Sponsor: Stanford University
Summary
This randomized controlled trial will evaluate the feasibility and acceptability of an inhaled aromatherapy stick for patients during the acute inpatient phase after hematopoietic cell transplantation (HCT) . The study will also explore whether aromatherapy use is associated with short-term changes in patient-reported cancer-related distress and coping self-efficacy.
Official title: Aromatherapy Inhaler Use for Hematopoietic Stem Cell Transplant Patient Distress
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-06-16
Completion Date
2026-06
Last Updated
2026-06-02
Healthy Volunteers
No
Interventions
Aromatherapy Stick
Participants receive aromatherapy inhaler education and an aromatherapy stick for self-administered inhalation during the early post-transplant inpatient period. Aromatherapy use occurs on the assigned Inhaler Use Day (targeted for Transplant Day +1, +2, or +3) and is documented using an inhaler use log. Total exposure is limited to a maximum of 2 hours.
Standard of Care
Participants receive standard inpatient supportive care during the acute post-HCT period. No aromatherapy inhaler is provided.
Locations (1)
Stanford University
Stanford, California, United States